06 Sep 2019
Friday 6th September, 10.00 – 13.00
Longitude Prize AMR diagnostic roundtable event: What role could new rapid diagnostic tests play in improving the use of antibiotics?
The National Council of Science Museums (NCSM) will hold an opening event for their exhibition: “Superbugs: The End of Antibiotics?” at National Science Center (Delhi). The exhibition, which has been developed in conjunction with the Science Museum Group, London, Wellcome Trust and ICMR, India explains the risks, challenges and strategies related to AMR. Included in the exhibition are five prototypes developed by teams that are competing to win the £8 million Longitude Prize.
The Longitude Prize AMR diagnostic roundtable event will take place on the same day as the exhibition opening. The diagnostics event will be built around diagnostic tests that appear in the Superbugs exhibition and other similar tests. Co-sponsored by NCSM (India), BIRAC (India), Science Museum Group (UK) and Longitude Prize/Nesta (UK).
Moderator: Dr Kamini Walia, Program officer AMR, Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research (ICMR) and Vikas Manchanda, Associate Professor, Department of Microbiology, Maulana Azad Medical College, Infection Control Officer, Lok Nayak Hospital, Govt of NCT of Delhi
Session I: Keynote opening address: India strategy to address the battle against resistance and efforts being taken to boost the development and implementation of rapid diagnostic tests.
Dr Sundeep Sarin, Advisor Scientist-G, Department of Biotechnology, Government of India
Session II: Snapshot of State-of-the-Art Diagnostics Development & role of Longitude Prize
Professor Till Bachmann, Edinburgh Medical School, University of Edinburgh
Session III: Longitude Prize diagnostic tests: What challenges are they addressing and how they will they make impact in the battle against resistance:
1. U-Sense, Module Innovations (India) UTI challenge in primary care and hospital settings
Speaker 1: Professor Varsha Gupta, Professor GMCH Chandigarh Speaker 2: Dr Sachin Dubey, CEO, Module Innovations Discussion
2. Viral vs bacterial infection tests developed by Attomarker (UK) Need for quick, rapid point of care test to reduce unnecessary antibiotic use in primary care settings
Speaker 1: Dr Dhanya Dharmapalan, Apollo Hospitals, primary care clinical researcher Speaker 2: Professor Andrew Shaw, CEO, Attomarker representative Discussion
3. RAPID, WeInnovate Biosolutions (India) and Septfilo, NanoDx (India) The need for faster identification of sepsis, antibiotic susceptibility testing and gram status identification for sepsis in emergency room and intensive care units
Speaker 1: Dr Sanjay Battacharya, Senior Consultant, Department of Microbiology, Tata Medical Center, Kolkata
Speaker 2: Dr Milind Choudhari, CEO, WeInnovate Biosolutions
Speaker 3: Dr Shalini Gupta, Technical Advisor, NanoDx
Speaker 4: Dr Sudeshna Adak, CEO and Director, Omix
Session IV: Open discussion and questions
Reception: Lunch
Registrations: Please RSVP to [email protected] if you plan to attend the roundtable.
